Cointime

Download App
iOS & Android

Greenlight Biosciences

company
Funding Round
Post-IPO Equity
Money Raised
$ 109M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
BNP Paribas Asset Management - - - Detail
Continental Grain Company - - - Detail
Cormorant Asset Management - - - Detail
Cummings Foundation - - - Detail
Fall Line Capital - - - Detail
FTX Foundation - - - Detail
Insud Pharma - - - Detail
Morningside Venture Investments - - - Detail
Rivas Capital - - - Detail
S2G Ventures - - - Detail
Sigmas Group - - - Detail
Symbiosis Group - - - Detail

Historical Financing

Announced Date Round Money Raised Investors
Feb 3, 2022 Post-IPO Equity $ 125.50M BNP Paribas Asset Management,Continental Grain Company,etc. Detail
Sep 13, 2017 Series D $ 18M Fall Line Capital,Kodiak Venture Partners,etc. Detail
Dec 20, 2013 Series A $ 1M Detail
Jan 8, 2019 Series Unknown $ 50M Alexandria Venture Investments,Baird Capital,etc. Detail
Jul 22, 2015 Series C 0 Syngenta Ventures Detail
Aug 12, 2013 Series A $ 7M Khosla Ventures,Kodiak Venture Partners Detail
May 12, 2020 Series Unknown $ 17M Baird Capital,Flu Lab,etc. Detail
Jun 17, 2015 Series B $ 20M Detail
Jun 16, 2020 Series D $ 102M AgFunder,Baird Capital,etc. Detail
Feb 3, 2022 IPO $ 282M Detail